[Prevalence of the metabolic syndrome among Italian adults. Findings from the SIMAP study].
The third report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (ATP III) highlights the importance of treating patients with the metabolic syndrome to prevent cardiovascular disease. Limited information is available about the prevalence of the metabolic syndrome in Italy. To estimate the prevalence of the metabolic syndrome in Italy as defined by the ATP III report, 367 men and 491 women aged 20 years or older were studied. Prevalence of the metabolic syndrome as defined by ATP III (3 of the following abnormalities: waist circumference greater than 102 cm in men and 88 cm in women; serum triglycerides level of at least 150 mg/dL; high-density lipoprotein cholesterol level of less than 40 mg/dL in men and 50 mg/dL in women; blood pressure of at least 130/85 mm Hg; or serum glucose level of at least 110 mg/dL) were 22.3% in men and 27.2% in women, respectively. These results show that the metabolic syndrome is highly prevalent.